The Tata Trust and The Global Fund backed Indian Health Fund (IHF) Monday announced that it had chosen four innovators, three related to tuberculosis and one to malaria in its goal of supporting national efforts to effectively tackle eradicate these diseases.

The aim for selecting them aims to leverage technology for improving early detection and prompt treatment along with promoting diagnostics feasible for primary health care facilities, an IHF statement said.

Now in its second year, the collaboration between the Tata Trusts and The Global Fund aims to discover solutions for crucial health challenges in India.

The government has set a target of eliminating TB by 2025 and malaria by 2030.

A statement of the IHF said the four innovators were selected from proposals received for its second Request for Proposals.

However, it did not disclose the quantum of assistance to these winners.

"The investment amount to these winners cannot be disclosed," a Tata Trust official said when asked.

The IHF was launched in 2016 by the Tata Trusts in collaboration with The Global Fund, to drive innovations towards key infectious disease challenges in India.

India contributes to 27 per cent of the global TB burden and 68 per cent of all malaria cases in the Southeast Asia region, the statement said.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)